Kazuo Iwasa

2.1k total citations
93 papers, 1.2k citations indexed

About

Kazuo Iwasa is a scholar working on Neurology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Kazuo Iwasa has authored 93 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Neurology, 22 papers in Molecular Biology and 11 papers in Psychiatry and Mental health. Recurrent topics in Kazuo Iwasa's work include Myasthenia Gravis and Thymoma (35 papers), Peripheral Neuropathies and Disorders (21 papers) and Autoimmune Neurological Disorders and Treatments (11 papers). Kazuo Iwasa is often cited by papers focused on Myasthenia Gravis and Thymoma (35 papers), Peripheral Neuropathies and Disorders (21 papers) and Autoimmune Neurological Disorders and Treatments (11 papers). Kazuo Iwasa collaborates with scholars based in Japan, United Kingdom and Norway. Kazuo Iwasa's co-authors include Masahito Yamada, Kiyonobu Komai, Masaharu Takamori, Hiroaki Yoshikawa, Kenjiro Ono, Moeko Noguchi‐Shinohara, Hiroyuki Nakamura, Yoshihisa Ikeda, Miharu Samuraki and Tsuyoshi Hamaguchi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Kazuo Iwasa

86 papers receiving 1.2k citations

Peers

Kazuo Iwasa

NEURO

PHYSI

CMN

PMH

Monika Białecka Poland

Lin Lü China

Tetsuya Asakawa Japan

Katherine E. Schwetye United States

Songyan Liu China

Giampiero Ferraguti Italy

Vijayshree Yadav United States

Mahsa Dolatshahi Iran

Edward Tobinick United States

Monika Białecka Poland

Kazuo Iwasa

597 ×1.1

NEURO

515 ×1.8

184 ×0.9

PHYSI

310 ×2.2

CMN

104 ×0.8

PMH

Citations per year, relative to Kazuo Iwasa Kazuo Iwasa (= 1×) peers Monika Białecka

Countries citing papers authored by Kazuo Iwasa

Since Specialization

Citations

This map shows the geographic impact of Kazuo Iwasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Iwasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Iwasa more than expected).

Fields of papers citing papers by Kazuo Iwasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Iwasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Iwasa. The network helps show where Kazuo Iwasa may publish in the future.

Co-authorship network of co-authors of Kazuo Iwasa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Iwasa. A scholar is included among the top collaborators of Kazuo Iwasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Iwasa. Kazuo Iwasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narita, Tomoko, Shunya Nakane, Akiko Nagaishi, et al.. (2023). Immunotherapy for ocular myasthenia gravis: an observational study in Japan. Therapeutic Advances in Neurological Disorders. 16. 4223444907–4223444907. 2 indexed citations

Nozaki, Ichiro, Akio Akagi, Junji Komatsu, et al.. (2021). Recovery from multidisciplinary therapy-refractory anti-NMDA receptor encephalitis after over three years of mechanical ventilation. Clinical Neurology and Neurosurgery. 202. 106477–106477. 1 indexed citations

Noguchi‐Shinohara, Moeko, Kenjiro Ono, Tsuyoshi Hamaguchi, et al.. (2020). Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression. Scientific Reports. 10(1). 18627–18627. 45 indexed citations

Iwasa, Kazuo, Hiroaki Yoshikawa, Yutaka Furukawa, & Masahito Yamada. (2018). Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis. Journal of Neuroimmunology. 325. 74–78. 11 indexed citations

Iwasa, Kazuo, Yutaka Furukawa, Hiroaki Yoshikawa, & Masahito Yamada. (2016). Caveolin-3 is aberrantly expressed in skeletal muscle cells in myasthenia gravis. Journal of Neuroimmunology. 301. 30–34. 6 indexed citations

Sakai, Kenji, Yoshihisa Ikeda, Chiho Ishida, et al.. (2015). Inclusion body myositis with granuloma formation in muscle tissue. Neuromuscular Disorders. 25(9). 706–712. 11 indexed citations

Iwasa, Kazuo, et al.. (2015). Vernet's syndrome induced by internal jugular vein thrombosis. Journal of Neurology Neurosurgery & Psychiatry. 87(11). 1252–1253. 3 indexed citations

Komatsu, Junji, et al.. (2014). Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene. Prion. 8(5). 336–338. 8 indexed citations

Yoshita, Mitsuhiro, Tsuyoshi Hamaguchi, Daisuke Yanase, et al.. (2012). Effect of Cognitive and Aerobic Training Intervention on Older Adults with Mild or No Cognitive Impairment: A Derivative Study of the Nakajima Project. Dementia and Geriatric Cognitive Disorders Extra. 2(1). 69–80. 30 indexed citations

10.

Takahashi, Ryoichi, Kenjiro Ono, Tokuhei Ikeda, et al.. (2012). Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy. Amyloid. 19(3). 129–132. 2 indexed citations

11.

Maruta, Takahiro, et al.. (2009). Autoantibody to dihydropyridine receptor in myasthenia gravis. Journal of Neuroimmunology. 208(1-2). 125–129. 9 indexed citations

12.

Ikeda, Tokuhei, Daisuke Noto, Moeko Noguchi‐Shinohara, et al.. (2009). CSF tau protein is a useful marker for effective treatment of superficial siderosis of the central nervous system: Two case reports. Clinical Neurology and Neurosurgery. 112(1). 62–64. 21 indexed citations

13.

Yoshikawa, Hiroaki, et al.. (2004). Comparative study of pre-operative thymic imaging and pathology in patients with myasthenia gravis. Journal of Clinical Neuroscience. 11(6). 610–613. 5 indexed citations

14.

Ono, Kenjiro, et al.. (2003). Sensorimotor polyneuropathy with 5-aminosalicylic acid: a case report. Journal of Clinical Neuroscience. 10(3). 386–389. 1 indexed citations

15.

Komai, Kiyonobu, et al.. (2000). Antibodies to Calcium Channel and Synaptotagmin in Lambert-Eaton Myasthenic Syndrome. The American Journal of the Medical Sciences. 319(4). 204–208. 19 indexed citations

16.

Doi, Tôru, Kazuo Iwasa, Takao Makifuchi, & Masaharu Takamori. (1999). White matter hyperintensities on MRI in a patient with corticobasal degeneration. Acta Neurologica Scandinavica. 99(3). 199–201. 11 indexed citations

17.

Iwasa, Kazuo, et al.. (1998). Motor Dysfunction and Autoantibodies in Spontaneous Thymoma Buffalo/Mna Rats. Annals of the New York Academy of Sciences. 841(1). 542–545. 1 indexed citations

18.

Iwasa, Kazuo, et al.. (1998). Decreased myocardial¹²³I-MIBG uptake in Parkinson's disease. Acta Neurologica Scandinavica. 97(5). 303–306. 53 indexed citations

19.

Iwasa, Kazuo, Kiyonobu Komai, & Masaharu Takamori. (1998). Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies. Muscle & Nerve. 21(12). 1655–1660. 30 indexed citations

20.

Shibata, Kaoru, et al.. (1997). Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines.. PubMed. 17(5A). 3345–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact